A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma

Bibliographic Details
Main Authors:	Weidong Wang, Wang Lv, Hui Wang, Yang Xu, Junrong Yan, Han-Ming Shen, Liqun Shan, Jian Hu
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2023-11-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304223000715

Internet